PRESS RELEASE published on 12/22/2025 at 15:21, 3 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group discloses a 4.94% interest in Just Group plc's 10p ordinary shares as of 19 December 2025, with details of sale transactions Disclosure Vanguard Group 10p Ordinary Shares Sale Transactions Just Group Plc
PRESS RELEASE published on 12/22/2025 at 15:20, 3 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses a 1.13% stake in International Personal Finance plc as of 19 Dec 2025, with recent sale of 10p ordinary shares Vanguard Group Financial Disclosure Stake Disclosure Share Sale International Personal Finance Plc
PRESS RELEASE published on 12/22/2025 at 15:20, 3 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses 4.71% stake in NCC Group plc as of 19 Dec 2025. Sale of 1p ordinary securities at 1.44 GBP disclosed on 22 Dec 2025 The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Securities Sale NCC Group Plc
PRESS RELEASE published on 12/22/2025 at 15:19, 3 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses a 4.97% stake in Unite Group plc, The on 19 December 2025 as per Form 8.3 under the Takeover Code Form 8.3 The Vanguard Group Takeover Code Stake Disclosure Unite Group Plc
BRIEF published on 12/19/2025 at 14:59, 3 months 19 days ago The Vanguard Group Discloses Position in American Axle & Manufacturing Form 8.3 Takeover Code Vanguard Group Securities Position American Axle
BRIEF published on 12/19/2025 at 14:58, 3 months 19 days ago The Vanguard Group Discloses Stake in JTC plc Takeover Code Securities Disclosure Vanguard Group Shareholding JTC Plc
BRIEF published on 12/19/2025 at 14:56, 3 months 19 days ago Vanguard Group Discloses Stakes in Avadel Pharmaceuticals Irish Takeover Panel Vanguard Group Form 8.3 Disclosure Equity Positions Avadel Pharmaceuticals
PRESS RELEASE published on 12/19/2025 at 14:54, 3 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.60% ownership position in American Axle & Manufacturing Holdings, Inc. with 9,016,245 relevant securities. Purchases and sales have been reported Securities The Vanguard Group Ownership Position Purchases And Sales American Axle & Manufacturing Holdings
PRESS RELEASE published on 12/19/2025 at 14:53, 3 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 5.09% stake in JTC plc, buying 11,817 securities at 12.83 GBP per unit Financial Transactions The Vanguard Group Stake Disclosure Securities Purchase JTC Plc
PRESS RELEASE published on 12/19/2025 at 14:51, 3 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses its 5.98% ownership in Avadel Pharmaceuticals plc through Form 8.3 under the Irish Takeover Panel rules The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Ownership Disclosure Avadel Pharmaceuticals Plc
Published on 04/07/2026 at 15:00, 2 hours ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 2 hours 15 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 2 hours 20 minutes ago bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 2 hours 30 minutes ago Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 2 hours 30 minutes ago Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Published on 04/07/2026 at 16:32, 28 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 30 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 2 hours ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 14:55, 2 hours 5 minutes ago Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 14:42, 2 hours 18 minutes ago Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition
Published on 04/07/2026 at 16:43, 16 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010318386
Published on 04/07/2026 at 14:44, 2 hours 16 minutes ago Statement of transactions in own shares from March 30, 2026 to April 2, 2026
Published on 04/07/2026 at 12:00, 5 hours ago Disclosure of shares outstanding and voting rights - 07.04.2026
Published on 04/07/2026 at 08:30, 8 hours 30 minutes ago Edenred achieves CDP “A” rating and joins the ranks of global leaders in climate action
Published on 04/07/2026 at 08:00, 9 hours ago Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats
